Molecular Mechanism of Mitochondrial Membrane Transport
线粒体膜运输的分子机制
基本信息
- 批准号:10610401
- 负责人:
- 金额:$ 41.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAddressAdoptedAffinityAllosteric RegulationApoptosisArchitectureBinding SitesBiophysicsCalciumCalcium BindingCalcium ChannelCalcium SignalingCalorimetryCationsCell DeathCell SurvivalCellsComplexCryoelectron MicroscopyCrystallographyDiseaseEpilepsyFutureGatekeepingHeart failureHomeostasisHomologous GeneHumanIon ChannelIonsLinkMediatingMetabolicMethodsMitochondriaMolecularMolecular ProbesMuscular DystrophiesMutationN-terminalNeurodegenerative DisordersNeuronsPathologyPhysiologicalPhysiological ProcessesPhysiologyPlayPost-Translational Protein ProcessingProcessProductionPropertyProtein IsoformsProteinsRegulationReperfusion InjuryResolutionRestRoleRouteRuthenium RedShapesSignal TransductionStructureTherapeuticTissuesTitrationsTransmembrane TransportWorkbasecalcium uniportercell growthdesignexcitotoxicityexperimental studyimprovedinhibitorinsightmitochondrial membranenovelnovel therapeuticspreventresponsetherapeutic targetuptake
项目摘要
PROJECT SUMMARY
Mitochondrial calcium (Ca2+) uptake is central to many fundamental physiological processes. It stimulates ATP
production during times of increased metabolic need and provides a Ca2+ sink to modulate Ca2+-mediated
signaling locally within a cell. Mitochondrial Ca2+ concentrations also regulate apoptosis and dysregulation––
specifically, Ca2+ overload––is a hallmark of pathologies ranging from neuronal excitotoxicity to heart failure and
some epilepsies to muscular dystrophies. Yet despite the importance of mitochondrial Ca2+ uptake in normal
physiology and disease, the molecular machinery mediating this process is relatively recently identified and many
fundamental questions remain to be answered.
The main route of Ca2+ influx to mitochondria is a channel called mitochondrial calcium uniporter, which
includes the ubiquitous pore-forming subunit MCU and, depending on the species, several regulatory subunits
(termed “uniplex” when in complex). This novel channel is highly selective for Ca2+, and its activity is tightly
regulated by cytosolic Ca2+ concentration.
My group recently determined a high-resolution crystal structure for a fungal MCU that defined a novel
channel architecture and revealed a high-affinity Ca2+-binding site. Moreover, our cryo-EM structure of the human
uniplex holocomplex revealed its architecture and hints at the mechanisms by which it is regulated. With these
structures and the methods we developed, my lab is uniquely poised to embark on the mechanistic
understanding of the mitochondrial calcium uniporter.
Here, we propose to: 1) elucidate the structural and biophysical basis of ion selectivity, conduction and
inhibition; 2) understand mechanisms of the channel gating and the long-range modulation; and 3) probe the
molecular basis of Ca2+-dependent regulation of the uniplex.
These results will give us much needed mechanistic insights into the activity and regulation of mitochondrial
calcium uniporter, expanding our understanding of general principles of Ca2+ channels. In addition, they should
provide a strong framework to aid the design of MCU inhibitors, which may represent promising treatments for
diseases and pathologies marked by MCU dysregulation and mitochondrial Ca2+ overload.
!
项目摘要
线粒体钙(Ca 2+)摄取是许多基本生理过程的核心。它能刺激ATP
在代谢需要增加的时间期间产生,并提供Ca 2+汇以调节Ca 2+介导的
在细胞内发出信号。线粒体Ca 2+浓度也调节细胞凋亡和失调--
具体地说,Ca 2+超载是从神经元兴奋性毒性到心力衰竭的病理学的标志,
从癫痫到肌肉萎缩症然而,尽管线粒体Ca 2+摄取在正常人中的重要性,
生理学和疾病,介导这一过程的分子机制是相对最近确定的,许多
一些根本性的问题仍有待回答。
Ca 2+流入线粒体的主要途径是一种称为线粒体钙单向转运体的通道,
包括普遍存在的孔形成亚基MCU和几个调节亚基,
(当在复合体中时称为“单重”)。这种新型通道对Ca 2+具有高度选择性,其活性与Ca 2+浓度密切相关。
受胞浆Ca ~(2+)浓度的调节。
我的团队最近确定了一种真菌MCU的高分辨率晶体结构,
通道结构,并揭示了高亲和力的Ca 2+结合位点。此外,我们的人体冷冻电镜结构
uniplex holocomplex揭示了它的结构,并暗示了它的调节机制。与这些
结构和我们开发的方法,我的实验室是独一无二的准备走上机械
了解线粒体钙单向转运体。
在这里,我们建议:1)阐明离子选择性,传导和
抑制; 2)了解通道门控和远程调制的机制; 3)探测
钙离子依赖性调节单链体的分子基础。
这些结果将为我们提供急需的关于线粒体活动和调节的机制见解
钙单向转运体,扩大我们对钙离子通道的一般原理的理解。此外,他们还应
提供了一个强有力的框架,以帮助设计MCU抑制剂,这可能是有前途的治疗,
以MCU失调和线粒体Ca 2+过载为标志的疾病和病理。
!
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Structure and thiazide inhibition mechanism of the human Na-Cl cotransporter.
- DOI:10.1038/s41586-023-05718-0
- 发表时间:2023-02
- 期刊:
- 影响因子:64.8
- 作者:Fan, Minrui;Zhang, Jianxiu;Lee, Chien-Ling;Zhang, Jinru;Feng, Liang
- 通讯作者:Feng, Liang
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Liang Feng其他文献
Liang Feng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Liang Feng', 18)}}的其他基金
Molecular mechanisms of gamma-secretase modulation central to Alzheimer’s disease
γ-分泌酶调节的分子机制对阿尔茨海默病至关重要
- 批准号:
10590920 - 财政年份:2022
- 资助金额:
$ 41.67万 - 项目类别:
Molecular Mechanism of Mitochondrial Membrane Transport
线粒体膜运输的分子机制
- 批准号:
10034915 - 财政年份:2020
- 资助金额:
$ 41.67万 - 项目类别:
Molecular Mechanism of Mitochondrial Membrane Transport
线粒体膜运输的分子机制
- 批准号:
10396663 - 财政年份:2020
- 资助金额:
$ 41.67万 - 项目类别:
Molecular Mechanism of Mitochondrial Membrane Transport
线粒体膜运输的分子机制
- 批准号:
10187602 - 财政年份:2020
- 资助金额:
$ 41.67万 - 项目类别:
Structure and Function of SWEET Sugar Transporters
SWEET糖转运蛋白的结构和功能
- 批准号:
10453739 - 财政年份:2016
- 资助金额:
$ 41.67万 - 项目类别:
Structure and Function of SWEET Sugar Transporters
SWEET糖转运蛋白的结构和功能
- 批准号:
10219289 - 财政年份:2016
- 资助金额:
$ 41.67万 - 项目类别:
Structure and Function of SWEET Sugar Transporters
SWEET糖转运蛋白的结构和功能
- 批准号:
9333389 - 财政年份:2016
- 资助金额:
$ 41.67万 - 项目类别:
Structure and Function of SWEET Sugar Transporters
SWEET糖转运蛋白的结构和功能
- 批准号:
10672222 - 财政年份:2016
- 资助金额:
$ 41.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 41.67万 - 项目类别:
Research Grant